INBP

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/08/2017
Contact Info
  • 225 Long Avenue
  • Hillside, NJ 07205

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-K
CIK 0001016504
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1980
Employees 115 a/o Sep 01, 2017
Company Officers/Contacts
E. Gerald Kay CEO
Dina L. Masi CFO, EVP
Christina Kay EVP
Riva Sheppard EVP
Company Directors
E. Gerald Kay Chairman, Compensation Committee Member
Robert Canarick Audit Committee Member, Compensation Committee Member
Carl DeSantis
Christina Kay
William Milmore Audit Committee Member, Compensation Committee Member
Riva Sheppard
Service Providers
Accounting/Auditing Firm
Friedman LLP
100 Engle Rock Avenue
East Hanover, NJ, 07936
United States
 
Securities Counsel
Herrick Feinstein LLP
Two Park Ave
New York, NY, 10016
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Integrated Health Technologies, Inc. until 4-03
  • Formerly=Chem International, Inc. until 1-01
INBP Security Details
Share Structure
Market Value1 $4,445,716 a/o Oct 20, 2017
Authorized Shares 50,000,000 a/o Oct 20, 2017
Outstanding Shares 21,170,074 a/o Oct 20, 2017
-Restricted 9,479,719 a/o Oct 20, 2017
-Unrestricted 11,690,355 a/o Oct 20, 2017
Held at DTC 9,674,698 a/o Oct 20, 2017
Float 9,214,073 a/o Sep 01, 2017
Par Value 0.002
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders
Shareholders of Record 106 a/o Sep 01, 2017
Short Selling Data
Short Interest 1,506 (15.31%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security